Across Channels
Trending Talks
Telitacicept vs Mycophenolate for IgAN
Nayan Arora
Rifaximin vs Low-FODMAP Diet in IBS: Non-Respon...
Anthony Kerbage
New AGA MASLD Guidelines: In T2D Proceed Direct...
Rifaximin vs Low-FODMAP Diet in IBS: Clinical T...
Anthony Kerbage
2-Year Follow Up: VISIONARY (sibeprenlimab)
Nayan Arora
Machine Learning Models for Diabetes Classifica...
Saurabh Zanwar, MD
Multiple Myeloma Insights
Freely Filtered
The podcast driving nephrology forward
Nephrology
Freely Filtered
Close button
Why are you reporting this TALK?